The diagnostic of hepatocellular adenoma (HCA) and hepatocellular carcinoma (HCC) has shifted from a classical morphological evaluation to a complex and precise morpho-molecular analysis that represents a core focus of the updated 6th edition of the WHO classification of digestive system tumours. Four molecular pathway...
Christine Sempoux, Young Nyun Park· Virchows Archiv· 0 citations
Metabolic dysfunction-associated steatohepatitis (MASH) is emerging as a leading driver of hepatocellular carcinoma (HCC), yet the molecular mechanisms linking metabolic stress, chronic inflammation and tumorigenesis remain poorly understood. Here we established a metabolically relevant, time-efficient MASH-to-HCC mode...
Hyunmi Kim, Gye-Hyeong Kim, H. Yeon et al.· Experimental and Molecular M...· 0 citations
Hepatocellular carcinoma (HCC) originates from premalignant disease-associated hepatocytes (daHeps) that emerge during the progression of metabolic dysfunction–associated steatotic liver disease (MASLD) to metabolic dysfunction–associated steatohepatitis (MASH). As daHeps are compensatorily primed by metabolic stress,...
Geun-Woo D. Kim, Dahee Choi, Soo-Young Kim et al.· Science Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.